HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Pisani Selected Research

agalsidase beta

1/2013Effects of switching from agalsidase Beta to agalsidase alfa in 10 patients with anderson-fabry disease.
2/2012Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy.
7/2009Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study.
11/2006Endocrine dysfunction in patients with Fabry disease.
7/2005[Fabry nephropathy in a female with superposed IgA glomerulonephritis].
8/2004Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.
3/2003[Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Pisani Research Topics

Disease

12Fabry Disease (Fabry's Disease)
09/2017 - 03/2003
8Dystonia (Limb Dystonia)
01/2021 - 11/2006
8Parkinson Disease (Parkinson's Disease)
02/2016 - 03/2000
6Dystonia musculorum deformans type 1
01/2021 - 11/2006
4Crohn Disease (Crohn's Disease)
05/2004 - 03/2000
3Infections
06/2021 - 05/2004
3Movement Disorders (Movement Disorder)
04/2015 - 03/2000
3Hypothyroidism
03/2011 - 12/2000
3Inborn Genetic Diseases (Disease, Hereditary)
03/2011 - 07/2001
2Disease Progression
12/2010 - 02/2007
2Dyskinesias (Dyskinesia)
02/2007 - 12/2005
2Proteinuria
07/2005 - 07/2001
2Ischemia
09/2002 - 04/2001
2Chronic Kidney Failure (Chronic Renal Failure)
05/2002 - 07/2001
2Thrombosis (Thrombus)
06/2000 - 01/2000
2Neointima
06/2000 - 01/2000
1COVID-19
01/2021
1Endocarditis
10/2020
1Myoclonic dystonia
12/2017
1Renal Insufficiency (Renal Failure)
12/2017
1Disorders of Excessive Somnolence (Hypersomnia)
01/2017
1Partial Epilepsies (Epilepsy, Partial)
01/2017
1Chorea (Rheumatic Chorea)
10/2015
1Inflammation (Inflammations)
06/2015
1Fragile X Tremor Ataxia Syndrome
08/2013
1Pain (Aches)
01/2013
1Hypertrophy
07/2009
1Migraine Disorders (Migraine)
12/2008
1Muscular Dystrophies (Muscular Dystrophy)
12/2007
1Overactive Urinary Bladder (Overactive Bladder)
05/2007
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2007
1Body Weight (Weight, Body)
11/2006
1Telangiectasis (Telangiectasia)
12/2004
1Hereditary Hemorrhagic Telangiectasia
12/2004
1Heart Diseases (Heart Disease)
08/2004
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
08/2004
1Lupus Nephritis
05/2004
1Necrosis
05/2004
1Pyuria
05/2004
1Lymphocele
05/2003
1Angiokeratoma
03/2003

Drug/Important Bio-Agent (IBA)

7agalsidase betaFDA Link
01/2013 - 03/2003
6Proteins (Proteins, Gene)FDA Link
01/2020 - 07/2001
6Cholinergic Agents (Cholinergics)IBA
04/2015 - 03/2000
5EnzymesIBA
09/2017 - 03/2003
5globotriaosylceramide (globotriosylceramide)IBA
09/2017 - 11/2006
5GalactosidasesIBA
06/2015 - 03/2003
3Pharmaceutical PreparationsIBA
12/2017 - 03/2000
3alpha-Galactosidase (Beano)IBA
09/2017 - 08/2004
3CalciumIBA
03/2011 - 11/2006
3SteroidsIBA
05/2004 - 03/2000
3Tacrolimus (Prograf)FDA LinkGeneric
05/2001 - 03/2000
2Acetylcholine (Acetylcholine Chloride)FDA Link
01/2021 - 04/2015
2Dopamine (Intropin)FDA LinkGeneric
01/2016 - 02/2007
2Cholinergic Antagonists (Anticholinergics)IBA
10/2015 - 07/2003
2GlycosphingolipidsIBA
10/2014 - 12/2010
2agalsidase alfaIBA
01/2013 - 07/2009
2Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
02/2007 - 07/2003
2Neutral GlycosphingolipidsIBA
08/2004 - 03/2003
2CreatinineIBA
05/2003 - 07/2001
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2002 - 01/2000
2Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2002 - 05/2002
2Arginine (L-Arginine)FDA Link
09/2002 - 05/2002
16- fluoro- 2- (4- (pyridin- 2- yl)but- 3- yn- 1- yl)imidazo(1,2- a)pyridineIBA
01/2021
1Muscarinic AntagonistsIBA
01/2021
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
12/2017
1perampanelIBA
01/2017
1PTEN-induced putative kinaseIBA
02/2016
1Biomarkers (Surrogate Marker)IBA
06/2015
1Biological ProductsIBA
06/2015
1UromodulinIBA
06/2015
1HydrolasesIBA
06/2015
1prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA
06/2015
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
04/2015
1Dopamine Receptors (Dopamine Receptor)IBA
10/2014
1ioflupaneIBA
08/2013
1Radioisotopes (Radionuclides)IBA
12/2008
1Anticonvulsants (Antiepileptic Drugs)IBA
12/2008
1DystrophinIBA
12/2007
1Sarcoglycans (beta Sarcoglycan)IBA
12/2007
1Glycoproteins (Glycoprotein)IBA
12/2007
1Levodopa (L Dopa)FDA LinkGeneric
05/2007
1AntibodiesIBA
11/2006
1Antipsychotic Agents (Antipsychotics)IBA
12/2005
1Capsules (Microcapsules)IBA
12/2004
1Immunosuppressive Agents (Immunosuppressants)IBA
05/2004
1Serum AlbuminIBA
05/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2004
1Monoclonal AntibodiesIBA
05/2004
1Infliximab (Remicade)FDA Link
05/2004
1Atorvastatin (Lipitor)FDA Link
09/2002

Therapy/Procedure

11Therapeutics
01/2021 - 03/2000
10Enzyme Replacement Therapy
12/2017 - 03/2003
2Stents
06/2000 - 01/2000
1Endoscopes
06/2021
1Transcatheter Aortic Valve Replacement
10/2020
1Duration of Therapy
07/2009
1Drug Therapy (Chemotherapy)
02/2007
1Deep Brain Stimulation
01/2006
1Renal Dialysis (Hemodialysis)
02/2005